The Hippo-YAP Signaling Pathway in Osteoarthritis and Rheumatoid Arthritis.

Min Li, Fang-Jie Zhang, Rui-Jun Bai
Author Information
  1. Min Li: Department of Orthopaedics, Wuxi Ninth People's Hospital, Soochow University, Wuxi, Jiangsu, 214000, People's Republic of China.
  2. Fang-Jie Zhang: National Clinical Research Center for Geriatric Disorders (Xiangya Hospital), Changsha, Hunan, 410008, People's Republic of China. ORCID
  3. Rui-Jun Bai: Department of Orthopaedics, Wuxi Ninth People's Hospital, Soochow University, Wuxi, Jiangsu, 214000, People's Republic of China.

Abstract

Arthritis is the most prevalent joint disease and is characterized by articular cartilage degradation, synovial inflammation, and changes in periarticular and subchondral bone. Recent studies have reported that Yes-associated protein (YAP) and the transcriptional coactivator with PDZ-binding motif (TAZ) have significant effects on the proliferation, migration, and survival of chondrocytes and fibroblast-like synovial cells (FLSs). YAP/TAZ signaling pathway, as well as the related Hippo-YAP signaling pathway, are responsible for the condition of cells and articular cartilage in joints. They are tightly regulated to maintain metabolism in chondrocytes and FLSs because abnormal expression may result in cartilage damage. However, the roles and mechanisms of the Hippo-YAP pathway in arthritis remain largely unknown. This review summarizes the roles and key functions of YAP/TAZ and the Hippo-YAP signaling pathway in FLSs and chondrocytes for the induction of proliferation, migration, survival, and differentiation in rheumatoid arthritis (RA) and osteoarthritis (OA) research. We also discuss the therapeutic strategies involving YAP/TAZ and the related Hippo-YAP signaling pathway involved in OA.

Keywords

References

  1. Genes Dev. 2010 Feb 1;24(3):235-40 [PMID: 20123905]
  2. Gastroenterology. 2017 Feb;152(3):533-545 [PMID: 28003097]
  3. Front Oncol. 2022 Jan 04;11:787814 [PMID: 35059315]
  4. Genes Dev. 2008 Jul 15;22(14):1962-71 [PMID: 18579750]
  5. Genes (Basel). 2016 Aug 30;7(9): [PMID: 27589805]
  6. Calcif Tissue Int. 2014 Dec;95(6):495-505 [PMID: 25311420]
  7. Oncogene. 1994 Aug;9(8):2145-52 [PMID: 8035999]
  8. Nat Cell Biol. 2003 Oct;5(10):914-20 [PMID: 14502294]
  9. J Mol Med (Berl). 2019 Jan;97(1):103-114 [PMID: 30465058]
  10. Lancet. 2015 Jul 25;386(9991):376-87 [PMID: 25748615]
  11. Circ Res. 2014 Jan 31;114(3):454-68 [PMID: 24276085]
  12. Nat Cell Biol. 2003 Oct;5(10):921-7 [PMID: 14502295]
  13. Development. 2020 Nov 12;147(21): [PMID: 32994166]
  14. Sci Transl Med. 2021 Jan 13;13(576): [PMID: 33441426]
  15. Cell Signal. 2020 Jun;70:109504 [PMID: 31857240]
  16. Sci Transl Med. 2020 Sep 16;12(561): [PMID: 32938794]
  17. Ann Rheum Dis. 2002 Nov;61 Suppl 2:ii78-81 [PMID: 12379630]
  18. Development. 1995 Apr;121(4):1053-63 [PMID: 7743921]
  19. Mol Immunol. 2020 Dec;128:258-267 [PMID: 33190006]
  20. Dev Cell. 2009 Mar;16(3):398-410 [PMID: 19289085]
  21. Front Cell Dev Biol. 2021 Apr 01;9:656153 [PMID: 33869221]
  22. Nat Commun. 2018 Nov 1;9(1):4564 [PMID: 30385786]
  23. Br Med Bull. 2013;105:185-99 [PMID: 23337796]
  24. J Clin Invest. 2012 Dec;122(12):4505-18 [PMID: 23143302]
  25. Arthritis Res Ther. 2022 Aug 8;24(1):188 [PMID: 35941675]
  26. Front Med (Lausanne). 2023 Feb 03;10:1029021 [PMID: 36817783]
  27. Arthritis Res Ther. 2015 May 30;17:147 [PMID: 26025096]
  28. Proc Natl Acad Sci U S A. 2010 May 4;107(18):8248-53 [PMID: 20404163]
  29. Ecotoxicol Environ Saf. 2021 Dec 1;225:112796 [PMID: 34555722]
  30. Development. 2002 Dec;129(24):5719-30 [PMID: 12421711]
  31. Nat Rev Drug Discov. 2014 Jan;13(1):63-79 [PMID: 24336504]
  32. J Immunol Res. 2020 Oct 22;2020:9510594 [PMID: 33145365]
  33. J Cell Physiol. 2007 Dec;213(3):626-34 [PMID: 17786965]
  34. Osteoarthritis Cartilage. 2019 Mar;27(3):359-364 [PMID: 30453055]
  35. Science. 2011 Apr 22;332(6028):458-61 [PMID: 21512031]
  36. Exp Cell Res. 2016 Apr 10;343(1):42-53 [PMID: 26524510]
  37. Front Physiol. 2022 Sep 02;13:954454 [PMID: 36117702]
  38. Cancer Cell. 2021 Aug 9;39(8):1115-1134.e12 [PMID: 34270926]
  39. Exp Gerontol. 2024 Jan;185:112336 [PMID: 38042379]
  40. Front Bioeng Biotechnol. 2022 Sep 19;10:998077 [PMID: 36199358]
  41. BMC Musculoskelet Disord. 2022 Feb 15;23(1):149 [PMID: 35168589]
  42. Mol Med Rep. 2020 Nov;22(5):4101-4106 [PMID: 33000236]
  43. Front Biosci (Elite Ed). 2012 Jan 01;4(1):74-100 [PMID: 22201856]
  44. Biochem Pharmacol. 2019 Jul;165:33-40 [PMID: 30826330]
  45. Curr Opin Cell Biol. 2016 Dec;43:62-68 [PMID: 27592171]
  46. Subcell Biochem. 2019;91:123-159 [PMID: 30888652]
  47. PLoS Biol. 2019 Apr 1;17(4):e3000201 [PMID: 30933975]
  48. Stem Cells Dev. 2013 Jul 15;22(14):2083-93 [PMID: 23442010]
  49. Int J Biochem Cell Biol. 2017 Jun;87:104-113 [PMID: 28438716]
  50. Sci Rep. 2020 Jan 13;10(1):157 [PMID: 31932746]
  51. J Int Med Res. 2008 Nov-Dec;36(6):1149-60 [PMID: 19094423]
  52. Biotechnol Lett. 2020 Sep;42(9):1645-1654 [PMID: 32451801]
  53. Bone. 2012 Aug;51(2):249-57 [PMID: 22387238]
  54. J Cell Physiol. 2007 Oct;213(1):1-8 [PMID: 17492773]
  55. Antioxidants (Basel). 2021 May 30;10(6): [PMID: 34070903]
  56. Arthritis Res Ther. 2009;11(3):224 [PMID: 19519926]
  57. Cell Metab. 2018 Aug 7;28(2):196-206 [PMID: 30089241]
  58. J Orthop Res. 2016 Jul;34(7):1121-9 [PMID: 26694636]
  59. Nat Rev Rheumatol. 2012 Nov;8(11):665-73 [PMID: 22868925]
  60. Curr Biol. 2008 Mar 11;18(5):311-21 [PMID: 18328708]
  61. Cell Discov. 2021 Apr 20;7(1):26 [PMID: 33879790]
  62. Oncogene. 2012 Apr 5;31(14):1743-56 [PMID: 21874053]
  63. Cell Rep. 2016 Mar 8;14(9):2224-2237 [PMID: 26923596]
  64. Int J Mol Med. 2021 Dec;48(6): [PMID: 34617577]
  65. Nat Rev Cardiol. 2019 Sep;16(9):519-537 [PMID: 31028357]
  66. Cell. 2007 Sep 21;130(6):1120-33 [PMID: 17889654]
  67. Theranostics. 2017 Jan 1;7(1):180-195 [PMID: 28042326]
  68. Cancer Cell. 2009 Nov 6;16(5):425-38 [PMID: 19878874]
  69. Nat Rev Dis Primers. 2018 Feb 08;4:18001 [PMID: 29417936]
  70. Genes Dev. 2010 Jan 1;24(1):72-85 [PMID: 20048001]
  71. Front Med (Lausanne). 2015 Sep 03;2:59 [PMID: 26389119]
  72. Cell. 2018 Mar 22;173(1):20-51 [PMID: 29570994]
  73. Osteoarthritis Cartilage. 2012 Dec;20(12):1484-99 [PMID: 22960092]
  74. Genes Dev. 2007 Nov 1;21(21):2747-61 [PMID: 17974916]
  75. Arthritis Res Ther. 2017 Feb 2;19(1):18 [PMID: 28148295]
  76. Ann Rheum Dis. 2022 Feb;81(2):214-224 [PMID: 34844926]
  77. Int J Mol Med. 2018 Dec;42(6):3181-3192 [PMID: 30320354]
  78. Ageing Res Rev. 2023 Sep;90:102015 [PMID: 37454824]
  79. Pharmaceuticals (Basel). 2023 Oct 11;16(10): [PMID: 37895911]
  80. Nat Rev Mol Cell Biol. 2019 Apr;20(4):211-226 [PMID: 30546055]
  81. Lancet. 2011 Jun 18;377(9783):2115-26 [PMID: 21684382]
  82. Phytomedicine. 2024 Jan;123:155243 [PMID: 38056147]
  83. Nat Med. 2014 Jun;20(6):599-606 [PMID: 24813251]
  84. Biochemistry. 2011 Apr 26;50(16):3300-9 [PMID: 21417403]
  85. ACS Biomater Sci Eng. 2019 Oct 14;5(10):5255-5265 [PMID: 33455230]
  86. Annu Rev Genet. 2018 Nov 23;52:65-87 [PMID: 30183404]
  87. Mol Cell Biol. 2008 Apr;28(7):2426-36 [PMID: 18227151]
  88. Front Immunol. 2021 Dec 09;12:791907 [PMID: 34956224]
  89. Mater Sci Eng C Mater Biol Appl. 2019 Nov;104:110007 [PMID: 31500008]
  90. Cell. 2005 Aug 12;122(3):421-34 [PMID: 16096061]
  91. Biomed Pharmacother. 2023 Dec;168:115772 [PMID: 37879209]
  92. Cells. 2019 Jul 17;8(7): [PMID: 31319599]
  93. Cell Prolif. 2023 Apr;56(4):e13380 [PMID: 36495056]
  94. Front Immunol. 2022 Aug 18;13:971416 [PMID: 36059522]
  95. Genes Dev. 2003 Oct 15;17(20):2514-9 [PMID: 14561774]
  96. Gene. 2019 Mar 20;689:210-219 [PMID: 30496783]
  97. Osteoarthritis Cartilage. 2010 Oct;18 Suppl 3:S17-23 [PMID: 20864019]
  98. Phytother Res. 2023 Nov;37(11):5205-5222 [PMID: 37527970]
  99. Cell. 2005 Mar 11;120(5):675-85 [PMID: 15766530]
  100. Front Cell Dev Biol. 2019 Apr 10;7:49 [PMID: 31024911]
  101. Cell Death Discov. 2022 Mar 12;8(1):111 [PMID: 35279674]
  102. Cell. 2002 Aug 23;110(4):467-78 [PMID: 12202036]
  103. Cell. 2003 Aug 22;114(4):457-67 [PMID: 12941274]
  104. Cancer Discov. 2022 Jan;12(1):31-46 [PMID: 35022204]
  105. J Cell Mol Med. 2021 Oct;25(19):9378-9389 [PMID: 34459110]
  106. J Inflamm Res. 2023 Mar 24;16:1283-1296 [PMID: 36998323]
  107. Nat Cancer. 2023 Jan;4(1):9-26 [PMID: 36564601]
  108. Curr Biol. 2007 Dec 4;17(23):2054-60 [PMID: 17980593]
  109. Biomaterials. 2020 Feb;232:119724 [PMID: 31918221]
  110. Biomed Pharmacother. 2019 Mar;111:1467-1477 [PMID: 30841462]
  111. Nat Rev Rheumatol. 2010 Nov;6(11):625-35 [PMID: 20924410]
  112. Food Funct. 2023 Nov 13;14(22):9999-10013 [PMID: 37856220]
  113. Cell Signal. 2021 Feb;78:109858 [PMID: 33253912]
  114. Exp Cell Res. 2018 May 15;366(2):81-91 [PMID: 29470961]
  115. Dev Cell. 2010 Jul 20;19(1):27-38 [PMID: 20643348]
  116. Nat Rev Drug Discov. 2012 Mar 01;11(3):234-50 [PMID: 22378270]
  117. Ann Rheum Dis. 2019 May;78(5):600-609 [PMID: 30808624]
  118. Cancers (Basel). 2018 Apr 10;10(4): [PMID: 29642615]
  119. Trends Biochem Sci. 2017 Nov;42(11):862-872 [PMID: 28964625]
  120. Oral Dis. 2023 May 15;: [PMID: 37184045]

Word Cloud

Created with Highcharts 10.0.0pathwayHippo-YAPchondrocytesYAP/TAZsignalingcartilageFLSsarthritisArthritisarticularsynovialproliferationmigrationsurvivalcellsrelatedrolesrheumatoidosteoarthritisOAprevalentjointdiseasecharacterizeddegradationinflammationchangesperiarticularsubchondralboneRecentstudiesreportedYes-associatedproteinYAPtranscriptionalcoactivatorPDZ-bindingmotifTAZsignificanteffectsfibroblast-likewellresponsibleconditionjointstightlyregulatedmaintainmetabolismabnormalexpressionmayresultdamageHowevermechanismsremainlargelyunknownreviewsummarizeskeyfunctionsinductiondifferentiationRAresearchalsodiscusstherapeuticstrategiesinvolvinginvolvedSignalingPathwayOsteoarthritisRheumatoidtherapy

Similar Articles

Cited By